Fig. 1
From: LncRNA-ANRIL regulates CDKN2A to promote malignant proliferation of Kasumi-1 cells
Elevated expression of LncRNA-ANRIL in AML. A. ANRIL expression levels in bone marrow samples from AML patients and healthy controls were analyzed using TCGA and GTEx databases. B. RT-qPCR quantification of ANRIL mRNA expression in clinical peripheral blood samples. *P < 0.05, **P < 0.01, ***P < 0.001